Company Overview and News

54
Another Contract In A Flurry Of Harsh-Environment Jobs

2018-09-22 seekingalpha
I discuss the contract and look at the broader picture for the harsh-environment segment of the market.
SDLP ESV NE NOBGF XOM N21 NOBGY SDRL RIG

 
Noble Corp. Buys Newbuild Jack-Up And Sets It On 3-Year Contract

2018-09-22 seekingalpha
Noble Corp. (NE) has just announced major news - the company is buying a newbuild jack-up from PaxOcean Group in connection with a concurrently awarded drilling control. The price tag is $93.75 million. Out of this sum, Noble paid $33.75 million in cash. The remaining sum, $60 million, was financed by the seller at a 4.25% interest rate paid in cash and 1.25% paid in kind. Seller financing is to be repaid in four years.
NE NOBGF N21 NOBGY

22
Oracle Corporation (ORCL) CEO Safra Catz and Mark Hurd on Q1 2019 Results - Earnings Call Transcript

2018-09-18 seekingalpha
Thank you, Victoria. Good afternoon, everyone, and welcome to Oracle’s first quarter fiscal year 2019 earnings conference call. A copy of the press release and financial tables, which includes the GAAP to non-GAAP reconciliation and other financial information, can be viewed and downloaded from our Investor Relations website.
SSREY 530017 FMCKI FMCKJ FREGP N21 ORCL FMCCO FMCCP NBL NOBGF FMCCM FMCCN FMCCK FMCCL FMCCI SIL FMCCJ FMCCG FMCKO LMHA FMCCH FMCKP ZBRA FMCKM LMHB FMCKN FMCKK FMCKL FREJN FREJO FREJP FMCC OCLCF NOBGY NUAN FMCCS LM SSREF

 
Precision Drilling Corporation Announces Addition of New Director

2018-09-13 globenewswire
CALGARY, Alberta, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Precision Drilling Corporation (“Precision”) is pleased to announce the addition of David W. Williams to its Board of Directors. Mr. Williams has over 35 years of experience in the offshore drilling industry having most recently served as Chairman, President and Chief Executive Officer of Noble Corporation from January 2008 to January 2018. Prior to joining Noble in 2006, Mr.
DO NOBGF N21 NOBGY PD DTK PDS

52
Will Jack-Up Rates Rise Rapidly?

2018-09-13 seekingalpha - 1
I continue the discussion on rig supply fundamentals, which began in my work on floater supply fundamentals.
SDLP NE ESV NOBGF N21 NOBGY SDRL RIG BDRLF

1
The Wall Street Journal: Bob Woodward’s new Trump book ‘Fear’ posts huge sales

2018-09-12 marketwatch
Reader interest in the inner workings of the Trump White House is showing no signs of fading.
CBS NOBGF CBS.A N21 NOBGY CPV CBS.WD

11
As Trump embraces more tariffs, US business readies public fight

2018-09-12 malaymail
WASHINGTON, Sept 12 — After months of waging a behind-the-scenes war against President Donald Trump's trade tariffs that have escalated far beyond what business groups once imagined, more than 60 US industry groups are launching a coalition today to take the fight public.
NOBGF XOM AZO GOOG MAT TGT HAS N21 GOOGL CVX NOBGY AAPL MSFT

11
RPT-As Trump embraces more tariffs, U.S. business readies public fight

2018-09-12 reuters
WASHINGTON, Sept 12 (Reuters) - After months of waging a behind-the-scenes war against President Donald Trump’s trade tariffs that have escalated far beyond what business groups once imagined, more than 60 U.S. industry groups are launching a coalition on Wednesday to take the fight public.
NOBGF XOM AZO GOOG MAT TGT HAS N21 GOOGL CVX NOBGY AAPL MSFT

11
As Trump embraces more tariffs, US business readies public fight

2018-09-12 channelnewsasia
After months of waging a behind-the-scenes war against President Donald Trump's trade tariffs that have escalated far beyond what business groups once imagined, more than 60 U.S. industry groups are launching a coalition on Wednesday to take the fight public.
NOBGF XOM AZO GOOG MAT TGT HAS N21 GOOGL CVX NOBGY AAPL MSFT

11
As Trump embraces more tariffs, U.S. business readies public fight

2018-09-12 reuters
WASHINGTON (Reuters) - After months of waging a behind-the-scenes war against President Donald Trump’s trade tariffs that have escalated far beyond what business groups once imagined, more than 60 U.S. industry groups are launching a coalition on Wednesday to take the fight public.
NOBGF XOM AZO GOOG MAT TGT HAS N21 GOOGL CVX NOBGY AAPL MSFT

 
Barnes & Noble shares soar after investor discusses sale with founder

2018-09-07 channelnewsasia
Shares of Barnes & Noble Inc jumped 20 percent on Friday, their best one-day percentage gain in over five years, after investor Richard Schottenfeld disclosed a higher stake and said he had discussed a possible sale of the bookseller with its founder and chairman.
NOBGF N21 NOBGY

 
Barnes & Noble shares soar after investor discusses sale with founder

2018-09-07 reuters
(Reuters) - Shares of Barnes & Noble Inc jumped 20 percent on Friday, their best one-day percentage gain in over five years, after investor Richard Schottenfeld disclosed a higher stake and said he had discussed a possible sale of the bookseller with its founder and chairman.
NOBGF N21 NOBGY

 
Barnes & Noble stock soars 16% after Schottenfeld fund increases stake, discusses acquisition potential

2018-09-07 marketwatch
Shares of Barnes & Noble Inc. BKS, +15.93% are up 15.9% in Friday morning trading after investor Richard Schottenfeld disclosed in a filing that he had increased his stake in the company to 6.9%, from 5.7% earlier this summer. He has amassed the stake through a number of funds, including the Schottenfeld Opportunities Fund II. The filing said that Schottenfeld intends to continue to engage in management discussions including "changes in company leadership at the executive and board level, implementation of operational improvements, and the desirability of selling the company.
NOBGF N21 NOBGY

52
Will Drillship Rates Rise Rapidly?

2018-09-07 seekingalpha - 1
I come to a conclusion that the market remains significantly oversupplied, and I don't see this problem solved in 2019 to allow for a doubling of rates in 2020.
SDLP NE ESV NOBGF N21 PACDQ NOBGY SDRL RIG

18
Consumer Cyclical WallStar Gains: Salem' 84%, International Game' 56%, And Unique's 50% Lead 50 In September

2018-09-06 seekingalpha
WallStars are distinguished by positive broker target price upsides. SALM, IGT, UFAB, SKIS, G, WYND, LVS, TUP, EVE, and ESCA topped the sector for broker price target upsides 9/5/18.
EVC NOBGF IGT SKIS LB FUN WYND CSS UFAB N21 CATO NOBGY BKS GM LVS TUP SALM

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 099742984